title: Age-related differences in amphetamine sensitization: effects of prior drug or stress history on stimulant sensitization in juvenile and adult rats.
abstract: Repeated intermittent exposure to stimulants progressively increases a drug's effect, with stressors capable of producing cross-sensitization to stimulants. Studies examining such sensitization during development are few, however, with results mixed. In Experiment 1, juvenile (P22) and adult (P64) female Sprague-Dawley rats were administered (daily for 4days) 1.5mg/kg or 3.0mg/kg amphetamine (1.5A and 3.0A groups), or saline (SAL group). In a second experiment, rats were exposed to either repeated restraint (60min/day for 4days; RS group) or were left non-manipulated in the home cage (NM group). Animals from both experiments were then challenged with 1.5mg/kg of amphetamine and sensitization assessed via locomotion and stereotypy after a 2-day and 3-wk washout period. When compared to SAL animals, 3.0A juveniles and adults exhibited evidence of locomotor sensitization 2days post-drug exposure, but this sensitization did not persist to the 3-week challenge. Compared to NM animals, RS animals showed stress-induced locomotor sensitization both 2days and 3weeks post-stress exposure, regardless of age. These results demonstrate that repeated drug/stress exposures prior to stimulant challenge are sufficient to induce behavioral sensitization among both juveniles and adults, with these effects particularly long-lasting following repeated stressor exposure.
authors.affiliation: Center for Development and Behavioral Neuroscience, Department of Psychology, Binghamton University, Binghamton, New York 13902-6000, USA.
authors.forename: Tamara L
authors.initials: TL
authors.lastname: Doremus-Fitzwater
authors.forename: Linda P
authors.initials: LP
authors.lastname: Spear
mesh_terms: D000367:Age Factors; D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D005260:Female; D008124:Locomotion / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D013239:Stereotyped Behavior / Q000187:drug effects; D013315:Stress, Psychological / Q000523:psychology*; D013997:Time Factors
chemical_list: D000697:Central Nervous System Stimulants; D000661:Amphetamine
references.citation: Pharmacol Biochem Behav. 2007 Jan;86(1):92-102
references.pmid: 17270257
references.citation: Psychopharmacology (Berl). 1984;84(3):431-5
references.pmid: 6440192
references.citation: Neuroscience. 2002;113(2):395-400
references.pmid: 12127096
references.citation: Pharmacol Biochem Behav. 1997 Sep;58(1):9-14
references.pmid: 9264063
references.citation: Neurosci Biobehav Rev. 1999 Nov;23(7):993-1010
references.pmid: 10580313
references.citation: J Neurosci. 1999 Nov 1;19(21):9579-86
references.pmid: 10531460
references.citation: Pharmacol Biochem Behav. 1992 Sep;43(1):307-13
references.pmid: 1409816
references.citation: Br J Pharmacol. 1992 Apr;105(4):849-56
references.pmid: 1504716
references.citation: Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91
references.pmid: 8401595
references.citation: Brain Res. 1998 Feb 2;783(1):133-42
references.pmid: 9479062
references.citation: Annu Rev Psychol. 2003;54:25-53
references.pmid: 12185211
references.citation: Physiol Behav. 2005 Jan 17;83(5):805-11
references.pmid: 15639166
references.citation: Dev Psychobiol. 2008 Jul;50(5):451-9
references.pmid: 18551462
references.citation: Drug Discov Today Dis Models. 2008 Winter;5(4):259-270
references.pmid: 20016773
references.citation: Neurosci Biobehav Rev. 1998 Mar;22(2):347-54
references.pmid: 9579324
references.citation: Horm Behav. 2004 Nov;46(4):458-66
references.pmid: 15465532
references.citation: Horm Behav. 2005 Jun;48(1):64-74
references.pmid: 15919386
references.citation: Psychopharmacology (Berl). 1990;100(3):377-82
references.pmid: 2315435
references.citation: Neurotoxicol Teratol. 1992 May-Jun;14(3):221-8
references.pmid: 1635542
references.citation: Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3137-46
references.pmid: 18640920
references.citation: J Pharmacol Exp Ther. 1995 Oct;275(1):345-57
references.pmid: 7562570
references.citation: Dev Psychobiol. 1983 Mar;16(2):83-109
references.pmid: 6339302
references.citation: Neuropharmacology. 1985 Sep;24(9):823-9
references.pmid: 4058677
references.citation: Brain Res. 1986 Jun;396(2):157-98
references.pmid: 3527341
references.citation: Psychopharmacology (Berl). 2009 Jan;201(4):589-99
references.pmid: 18797848
references.citation: Science. 1983 Mar 4;219(4588):1091-3
references.pmid: 6681679
references.citation: Pharmacol Biochem Behav. 1980 Dec;13(6):777-80
references.pmid: 7208545
references.citation: Pharmacol Biochem Behav. 1986 May;24(5):1225-8
references.pmid: 3725828
references.citation: Psychopharmacology (Berl). 1991;103(4):480-92
references.pmid: 2062986
references.citation: Brain Res Dev Brain Res. 2002 Sep 20;138(1):27-34
references.pmid: 12234655
references.citation: Neurosci Biobehav Rev. 2003 Jan-Mar;27(1-2):163-78
references.pmid: 12732232
references.citation: Psychopharmacology (Berl). 1984;84(4):466-75
references.pmid: 6441946
references.citation: Brain Res Dev Brain Res. 1998 Nov 1;111(1):25-33
references.pmid: 9804875
references.citation: Pharmacol Biochem Behav. 2005 Oct;82(2):280-8
references.pmid: 16199081
references.citation: Neuropsychopharmacology. 2007 Mar;32(3):625-37
references.pmid: 16794567
references.citation: Psychopharmacology (Berl). 2005 Dec;183(2):218-25
references.pmid: 16175404
references.citation: Behav Neurosci. 1998 Oct;112(5):1152-66
references.pmid: 9829793
references.citation: Behav Brain Res. 2006 Sep 25;172(2):360-4
references.pmid: 16822557
references.citation: Neuroscience. 1999;92(1):343-52
references.pmid: 10392855
references.citation: Eur J Pharmacol. 2010 Feb 10;627(1-3):150-5
references.pmid: 19879869
references.citation: Int J Neuropsychopharmacol. 2006 Aug;9(4):377-92
references.pmid: 16316481
references.citation: Science. 1980 Jan 18;207(4428):329-31
references.pmid: 7188649
references.citation: Brain Res. 1990 Apr 23;514(1):22-6
references.pmid: 2357527
references.citation: Psychopharmacology (Berl). 1982;76(4):310-5
references.pmid: 6812103
references.citation: Pharmacol Biochem Behav. 1999 Jun;63(2):263-9
references.pmid: 10371655
references.citation: Addict Biol. 2005 Sep;10(3):251-6
references.pmid: 16109586
references.citation: Pharmacol Biochem Behav. 2001 Jan;68(1):115-24
references.pmid: 11274716
references.citation: Yakubutsu Seishin Kodo. 1992 Feb;12(1):17-25
references.pmid: 1414027
references.citation: Behav Neurosci. 2008 Aug;122(4):861-75
references.pmid: 18729640
references.citation: Psychopharmacology (Berl). 2008 May;198(1):51-62
references.pmid: 18415082
references.citation: Pharmacol Biochem Behav. 1998 Aug;60(4):909-14
references.pmid: 9700975
references.citation: Brain Res. 1992 Dec 11;598(1-2):343-8
references.pmid: 1486498
references.citation: Neuroscience. 2004;123(4):857-65
references.pmid: 14751279
references.citation: Life Sci. 1985 Sep 16;37(11):1039-42
references.pmid: 4041000
references.citation: Psychopharmacology (Berl). 1999 Feb;142(2):200-8
references.pmid: 10102773
references.citation: Physiol Behav. 2002 Aug;76(4-5):457-63
references.pmid: 12126980
references.citation: Dev Psychobiol. 2008 Mar;50(2):127-33
references.pmid: 18286579